Salvage-line of Capecitabine Plus Oxaliplatin Therapy (XELOX) for Patients With Inoperable/Advanced Gastric Cancer Resistant/Intolerant to Cisplatin (OGSG1403)

NAOTOSHI SUGIMOTO, JUNJI KAWADA, YOSHIO OKA, SHUGO UEDA, KOHEI MURAKAMI, KAZUHIRO NISHIKAWA, YUKINORI KUROKAWA, KAZUMASA FUJITANI,HISATO KAWAKAMI, SHUNJI ENDO, DAISUKE SAKAI, TOSHIO SHIMOKAWA, TAROH SATOH

Anticancer research 45: 307-313 (2025)　 doi:10.21873/anticanres.17418　Published online: 2024.12.31